During the 1970s and 1980s, thousands of individuals with haemophilia received blood products contaminated with HIV and hepatitis, obtained from donors who unknowingly carried these viruses. This included patients needing transfusions after childbirth or surgery. The NHS introduced Factor VIII during this period as an advanced treatment for haemophilia and Von Willebrand Syndrome, significantly enhancing patient care compared to earlier methods. However, the inherent risk of contamination meant that even a single infected donor could affect the entire batch of Factor VIII.

Q7. During the 1970s and 1980s, thousands of individuals with haemophilia received blood products contaminated with HIV and hepatitis, obtained from donors who unknowingly carried these viruses. This included patients needing transfusions after childbirth or surgery. The NHS introduced Factor VIII during this period as an advanced treatment for haemophilia and Von Willebrand Syndrome, significantly enhancing patient care compared to earlier methods. However, the inherent risk of contamination meant that even a single infected donor could affect the entire batch of Factor VIII.

The NHS imported Factor VIII from the United States, where a substantial portion of donated plasma came from paid donors, including prisoners and intravenous drug users. This practice unintentionally introduced HIV and hepatitis into the blood supply, leading to widespread infections. An inquiry estimated that more than 30,000 people contracted HIV, hepatitis C, or both as a result, with a significant number of hepatitis C cases observed among transfusion recipients. Shockingly, approximately 380 children were infected with HIV.

Tragically, nearly two-thirds of those infected with HIV later succumbed to AIDS-related illnesses, and there were instances where the virus was transmitted to their partners. In 2024, you are a Director General of the NHS appointed by the government, and addressing the legacy of this medical tragedy remains your solemn responsibility. (20M)

In the given circumstances, address the following:

• Identify the main stakeholders involved in this case. Highlight the issues related to integrity and ethics in the case above. As the current Director General of NHS what will be your course of action?

• Identify the main stakeholders involved in this case.

• Highlight the issues related to integrity and ethics in the case above.

• As the current Director General of NHS what will be your course of action?

Difficulty Level: Medium

Why the question? The ethical, administrative, and policy-level responsibilities in handling the legacy of a major healthcare disaster, emphasizing accountability, reparative justice, and systemic reforms. Key Demand of the Question: The question requires identification of stakeholders, ethical and integrity issues involved, and actionable measures as the current Director General of NHS to address past failures and prevent future occurrences. Structure of the Answer: Introduction: Briefly contextualize the situation by mentioning the healthcare disaster caused by contaminated blood products and its long-term implications, highlighting the need for addressing the ethical lapses and restoring trust. Body: Stakeholders: Identify the key groups affected or involved, including patients, healthcare providers, regulatory bodies, and policymakers. Ethical and integrity issues: Discuss the lack of transparency, accountability, and due diligence in procurement and communication, emphasizing the ethical principles violated. Course of action: Propose immediate measures for acknowledgment, investigation, and compensation, coupled with long-term reforms in procurement, ethical training, and stakeholder engagement. Conclusion: Conclude with the importance of rectifying past wrongs through accountability and ethical reforms while emphasizing the need to rebuild public trust and ensure future healthcare integrity.

Why the question? The ethical, administrative, and policy-level responsibilities in handling the legacy of a major healthcare disaster, emphasizing accountability, reparative justice, and systemic reforms.

Key Demand of the Question: The question requires identification of stakeholders, ethical and integrity issues involved, and actionable measures as the current Director General of NHS to address past failures and prevent future occurrences.

Structure of the Answer:

Introduction: Briefly contextualize the situation by mentioning the healthcare disaster caused by contaminated blood products and its long-term implications, highlighting the need for addressing the ethical lapses and restoring trust.

• Stakeholders: Identify the key groups affected or involved, including patients, healthcare providers, regulatory bodies, and policymakers.

• Ethical and integrity issues: Discuss the lack of transparency, accountability, and due diligence in procurement and communication, emphasizing the ethical principles violated.

• Course of action: Propose immediate measures for acknowledgment, investigation, and compensation, coupled with long-term reforms in procurement, ethical training, and stakeholder engagement.

Conclusion: Conclude with the importance of rectifying past wrongs through accountability and ethical reforms while emphasizing the need to rebuild public trust and ensure future healthcare integrity.